- Advertisement -

Killer Cells Lay Mines to Blast Cancerous, Infected Cells

Cytotoxic T lymphocytes (CTLs) are versatile killers. When they detect a target—a cell infected by a virus or deranged by cancer—they can release soluble...

What’s next for the biotechnology market? – SciTech Europa

© iStcok/Kkolosov SciTech Europa welcomes Sumant Ugalmugale to discuss Global Market Insight’s new study which predicts the growth of the biotechnology market. Biotechnology Market size was...

Specific Gut Bacteria Linked with Protein Aggregation Characteristic of Parkinson’s, Alzheimer’s Diseases

Recent research suggests that people with neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), exhibit changes in the bacterial...

Chongqing Sidemu Biotechnology Technology – Genetic Engineering & Biotechnology News

Candidate: Natural killer (NK) cell therapy Type: Universal off-the-shelf NKG2D-ACE2 CAR-NK cells Status: Chongqing Sidemu Biotechnology Technology and sponsor Chongqing Public Health Medical Center disclosed March...

New drug candidate uses novel absorption method to target cancer cells...

A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut’s lymphatic system rather than blood...

How Organoids Are Revolutionizing Neuroscience Research

Panelists: Angels Almenar-Queralt, PhD Assistant ProfessorUniversity of California, San Diego View Bio...

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

Biotechnology company SonoThera has raised $125 million in an oversubscribed Series B financing round. The financing was led by Vida Ventures, with participation from...

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

Biotechnology company SonoThera has raised $125 million in an oversubscribed Series B financing round. The financing was led by Vida Ventures, with participation from...

Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins

You know when you are at the eye doctor getting an updated prescription, and suddenly the world snaps into sharper focus? Physicists at the...

more new items

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

In what’s shaping up to be a historic year for biotech initial public offerings, Parabilis Medicines (Nasdaq: PBLS) made its mark on Wall Street this past week...

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

Biotechnology company SonoThera has raised $125 million in an oversubscribed Series B financing round. The financing was led by Vida Ventures, with participation from...

Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins

You know when you are at the eye doctor getting an updated prescription, and suddenly the world snaps into sharper focus? Physicists at the...